185 related articles for article (PubMed ID: 26476684)
1. Interleukin 19 reduces inflammation in chemically induced experimental colitis.
Matsuo Y; Azuma YT; Kuwamura M; Kuramoto N; Nishiyama K; Yoshida N; Ikeda Y; Fujimoto Y; Nakajima H; Takeuchi T
Int Immunopharmacol; 2015 Dec; 29(2):468-475. PubMed ID: 26476684
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis.
Fujimoto Y; Azuma YT; Matsuo Y; Kuwamura M; Kuramoto N; Miki M; Azuma N; Teramoto M; Nishiyama K; Izawa T; Nakajima H; Takeuchi T
Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):261-268. PubMed ID: 27942772
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
6. IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis.
Jin Y; Lin Y; Lin L; Zheng C
J Interferon Cytokine Res; 2012 Nov; 32(11):548-56. PubMed ID: 23030668
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-19 protects mice from innate-mediated colonic inflammation.
Azuma YT; Matsuo Y; Kuwamura M; Yancopoulos GD; Valenzuela DM; Murphy AJ; Nakajima H; Karow M; Takeuchi T
Inflamm Bowel Dis; 2010 Jun; 16(6):1017-28. PubMed ID: 19834971
[TBL] [Abstract][Full Text] [Related]
8. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
9. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
[TBL] [Abstract][Full Text] [Related]
12. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.
Dohi T; Fujihashi K; Kiyono H; Elson CO; McGhee JR
Gastroenterology; 2000 Sep; 119(3):724-33. PubMed ID: 10982767
[TBL] [Abstract][Full Text] [Related]
13. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis.
Zhang Z; Zheng M; Bindas J; Schwarzenberger P; Kolls JK
Inflamm Bowel Dis; 2006 May; 12(5):382-8. PubMed ID: 16670527
[TBL] [Abstract][Full Text] [Related]
14. IRF4 selectively controls cytokine gene expression in chronic intestinal inflammation.
Mudter J; Yu J; Amoussina L; Weigmann B; Hoffman A; Rücknagel K; Galle PR; Neurath MF
Arch Immunol Ther Exp (Warsz); 2009; 57(5):369-76. PubMed ID: 19693649
[TBL] [Abstract][Full Text] [Related]
15. The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis.
Shi T; Xie Y; Fu Y; Zhou Q; Ma Z; Ma J; Huang Z; Zhang J; Chen J
Mucosal Immunol; 2017 Jul; 10(4):983-995. PubMed ID: 27901018
[TBL] [Abstract][Full Text] [Related]
16. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
19. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
20. Rapid development of colitis in NSAID-treated IL-10-deficient mice.
Berg DJ; Zhang J; Weinstock JV; Ismail HF; Earle KA; Alila H; Pamukcu R; Moore S; Lynch RG
Gastroenterology; 2002 Nov; 123(5):1527-42. PubMed ID: 12404228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
